about
Beating the Odds: Successful Establishment of a Phase II/III Clinical Research Trial in Resource-Poor Liberia during the Largest-Ever Ebola OutbreakTrends in Research with U.S. Military Service Member Participants: A Population-Specific ClinicalTrials.gov Review.Lifestyle modification intervention for overweight and obese Hispanic pregnant women: development, implementation, lessons learned and future applications.Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania.A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL.Mexican-American perspectives on participation in clinical trials: A qualitative study.The Recruitment Experience of a Randomized Clinical Trial to Aid Young Adult Smokers to Stop Smoking without Weight Gain with Interactive Technology.A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material.Assessment of Adherence to Visual Correction and Occlusion Therapy in the Infant Aphakia Treatment Study.Application of the Marginal Structural Model to Account for Suboptimal Adherence in a Randomized Controlled Trial.Teleconsent: A Novel Approach to Obtain Informed Consent for Research.School-based mindfulness intervention for stress reduction in adolescents: Design and methodology of an open-label, parallel group, randomized controlled trial.Study design and baseline results of an open-label cluster randomized community-intervention trial to assess the effectiveness of a modified mass deworming program in reducing hookworm infection in a tribal population in southern India.Recruitment and baseline characteristics of the Community of Voices choir study to promote the health and well-being of diverse older adults.Successful collection of stool samples for microbiome analyses from a large community-based population of elderly men.Design and Rationale for a Technology-based Healthy Lifestyle Intervention in Older Adults Grieving the Loss of a Spouse.Wearable technology to reduce sedentary behavior and CVD risk in older adults: design of a randomized controlled trial.Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.Metabolic costs of daily activity in older adults (Chores XL) study: design and methods.Statistical Analysis Plan for Stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) Study.Falls as Adverse Events in Psychosocial Treatment of Depression: Findings from a Clinical Trial in Nursing Homes.Real-Time Enrollment Dashboard For Multisite Clinical Trials.Quantifying and visualizing site performance in clinical trials.CREATE Wellness: A multi-component behavioral intervention for patients not responding to traditional Cardiovascular disease management.Sensitivity of adaptive enrichment trial designs to accrual rates, time to outcome measurement, and prognostic variables.External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial.IMPLEMENTATION, RECRUITMENT AND BASELINE CHARACTERISTICS: A RANDOMIZED TRIAL OF COMBINED TREATMENTS FOR SMOKING CESSATION AND WEIGHT CONTROL.TelePain: Primary Care Chronic Pain Management through Weekly Didactic and Case-based Telementoring.Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool (iCanDecide).Research site mentoring: A novel approach to improving study recruitment.A gender- and culturally-sensitive weight loss intervention for Hispanic males: The ANIMO randomized controlled trial pilot study protocol and recruitment methods.Exclusion criteria and generalizability in bipolar disorder treatment trials.Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigators.Serious adverse events of older adults in nursing home and community intervention trials.Barriers to non-small cell lung cancer trial eligibility.Bayesian adaptive clinical trials of combination treatments.Feasibility of high-intensity interval training with hyperoxia vs. intermittent hyperoxia and hypoxia in cancer patients undergoing chemotherapy - Study protocol of a randomized controlled trial.Supervised pelvic floor muscle training versus attention-control massage treatment in patients with faecal incontinence: Statistical analysis plan for a randomised controlled trial.Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project.Efficacy of antiviral drug AV2 in the treatment of human papillomavirus-associated precancerous lesions of the uterine cervix: A randomized placebo-controlled clinical trial in Kinshasa, DR Congo. (KINVAV study).
P1433
Q28397519-1A651F00-9829-48CA-A0A9-2396E6FE073DQ50866738-31E6E6A8-19FE-4666-81F1-DDAE6161E262Q50866743-C2ADB2C1-584E-4B9B-8A0D-B1BB63AB40FBQ50878517-9AF25B12-3FA7-4437-A6FD-3E5377EAB546Q50901017-EFF34B03-7886-4AE8-B9AF-A44FE4BD8E01Q50905419-511E7776-4322-4998-8F6E-DDF28293669AQ50922662-31988210-AAEC-4FC1-9A93-947FD6201B0FQ50922963-CA1A6E87-2E18-457E-97C1-D38E506A4808Q51008474-F789789E-BAFD-4581-9C80-AC9B562ED66EQ51036797-6FD7CA9D-0399-4AC2-AC08-336560B5B68AQ51073588-77296C07-E916-4318-AA3A-3452F21A4642Q51134881-79E6D328-02A0-47F3-869F-A006E18A60ADQ51339334-A20F31C0-7316-49B9-ADA1-032F2762175FQ51770968-BB1E7BE9-BF19-4AEC-960E-EB05A2632A9EQ51777161-29A4BEF2-BF29-403E-A851-7C370377025CQ51781382-56B499A0-E446-43A5-B275-C3D3ED9D06C9Q51795104-E6F5629E-F16F-449D-BDBC-792FA415AC4DQ51807855-4BC15034-7C8A-4218-9659-848561F96592Q51813667-B67817EB-E366-45B7-ABE4-C31CA3DEE5DCQ52089873-E6BDAAB9-583A-4088-BBC4-B56A79DBBF5FQ52114915-78F88AC2-86FF-4879-BC51-CD70309FDF7DQ52144655-65ABA5A8-B1CA-4EFD-9F93-858FB338E368Q52309319-7814C17B-C1E8-4376-A518-9251F7740BE9Q52309326-B0AC0AE4-2F35-4EC9-B564-CD364D878E4DQ52309328-014F377B-73B1-4C13-89CD-3C7194694CA1Q52312736-F3390DD7-BBB4-4B74-8F7F-727E41EBBB54Q52314618-F35A544C-142B-4598-A8EA-204E0952200EQ52316003-C86FA4B7-65A2-4B06-8601-295861361173Q52431865-D82A1EC0-35F7-4DA1-A410-6B70A79F4D8EQ52562479-D0879BFF-4531-4B34-B3C4-71CCDECE819BQ52562481-7F79D2EA-E950-4214-80C0-FD9DA9B18A36Q52562484-0C97FDDD-6740-4EB1-9E4E-9231EA0967E1Q52562486-C903BC96-A1D7-4E61-B03E-1715766ED59CQ52562488-AF1505CA-FB02-4118-A92A-4C19DA044428Q52562491-82F80C02-A0E6-478E-AA3F-E424113D1F31Q52562503-ED0D27CC-774B-4049-81E4-FF432E696AD1Q52562506-88096B83-6A13-4BB0-A609-C2FD4CFCEA72Q52562508-D3CC23DA-6836-4C9F-B358-E589B823A595Q52562510-0DE163C0-429D-4C57-9E0E-4AB325A1BE6CQ52562511-D416236F-333B-4BD8-BFCB-0C8828EE2119
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Contemporary clinical trials communications
@ast
Contemporary clinical trials communications
@en
Contemporary clinical trials communications
@es
Contemporary clinical trials communications
@nl
type
label
Contemporary clinical trials communications
@ast
Contemporary clinical trials communications
@en
Contemporary clinical trials communications
@es
Contemporary clinical trials communications
@nl
altLabel
Contemp Clin Trials Commun
@en
Contemporary Clinical Trials Communications
@en
prefLabel
Contemporary clinical trials communications
@ast
Contemporary clinical trials communications
@en
Contemporary clinical trials communications
@es
Contemporary clinical trials communications
@nl
P31
P1055
P1156
21100446418
P123
P1476
Contemporary clinical trials communications
@en
P236
P5115
P5963
contemporary-clinical-trials-communications